5th European Investigator Initiated Trials

Exl Pharma’s 5th European Investigator Initiated Trials Conference is the foremost event that provides executives with a forum to network and learn from leading experts on how to improve strategies for IITs. As the technological and regulatory landscape continues to transform, the pharmaceutical and biotech industries must continue to adapt processes to remain compliant.

You will hear case studies on working with investigators, and ways to implement GCPs. This summit features best practices on improving funding, intellectual property, and contracting strategies. Your company will stay ahead of the curve by preparing for increases in regulation, including the possibility of audits, reviews and inspections.

Top Reasons to Attend

• This year’s conference provides a place to discuss upcoming changes in regulatory legislation and will provide case studies on preparing for potential inspection, audits and reviews.
• Review the most recent released EU directives on standards for documentation practices and learn the strategies to ensure compliance with paperwork and safety reporting.
• Learn key elements in working with investigators by ensuring motivation and GCPs by providing education and support.
• Improve contracting with investigators and organizations by setting clear expectations on intellectual property ownership.
• Learn best practices to determining fair market value and the tools available to measure accurate payments.